Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

What is ‘LDL cholesterol’?

LDL cholesterol is an important contributor to the risk of coronary heart disease, and its measurement is central to evaluating the effects of lipid-modifying therapies. Several ‘LDL-cholesterol’ assays exist but their methodologies differ, leading to between-assay heterogeneity in values of ‘LDL cholesterol’. We advocate the need for awareness of the potential implications.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Circulating, apoB-containing lipoproteins and methods for quantifying ‘LDL cholesterol’.

References

  1. 1.

    HPS3/TIMI55-REVEAL Collaborative Group. Effects of anacetrapib in patients with atherosclerotic vascular disease. N. Engl. J. Med. 377, 1217–1227 (2017).

    Article  Google Scholar 

  2. 2.

    Boren, J. & Williams, K. J. The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr. Opin. Lipidol. 27, 473–483 (2016).

    CAS  Article  Google Scholar 

  3. 3.

    Kettunen, J. et al. Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition. Preprint at bioRxiv https://doi.org/10.1101/295394 (2018).

    Article  Google Scholar 

  4. 4.

    Sliz, E. et al. Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment. Circulation 138, 2499–2512 (2018).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

M.V.H. is supported by a British Heart Foundation Intermediate Clinical Research Fellowship (FS/18/23/33512). M.A.-K. is supported by a Senior Research Fellowship from the National Health and Medical Research Council (NHMRC) of Australia (APP1158958) and works in a Unit that is supported by the University of Bristol and UK Medical Research Council (MC_UU_12013/1).

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Michael V. Holmes or Mika Ala-Korpela.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Holmes, M.V., Ala-Korpela, M. What is ‘LDL cholesterol’?. Nat Rev Cardiol 16, 197–198 (2019). https://doi.org/10.1038/s41569-019-0157-6

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing